Immunocytochemical investigation on dysplastic human tissue from epileptic patients.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 9761307)

Published in Epilepsy Res on September 01, 1998

Authors

R Spreafico1, B Pasquier, L Minotti, R Garbelli, P Kahane, S Grand, A L Benabid, L Tassi, G Avanzini, G Battaglia, C Munari

Author Affiliations

1: Department of Neurophysiology, National Neurological Institute C. Besta, Milano, Italy. spreafico.besta@interbusiness.it

Articles by these authors

Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med (1998) 4.72

A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med (1995) 3.98

Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet (1995) 3.06

Terminology and classification of the cortical dysplasias. Neurology (2004) 2.99

Mapping of genes predisposing to idiopathic generalized epilepsy. Hum Mol Genet (1995) 2.65

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol (2001) 2.45

Interictal spikes in focal epileptogenesis. Prog Neurobiol (2001) 2.33

Supratentorial cavernous angiomas and epileptic seizures: preoperative course and postoperative outcome. Neurosurgery (1996) 2.29

Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain (2002) 2.17

The impact on Parkinson's disease of electrical parameter settings in STN stimulation. Neurology (2002) 2.14

Coexistence of plasma cell granulomas of lung and central nervous system. Pathol Res Pract (1995) 2.13

Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet (2004) 1.88

Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease. Neurology (2000) 1.85

Cortical dysplasia: an immunocytochemical study of three patients. Neurology (1998) 1.83

(-)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection. Neuropharmacology (2003) 1.82

High-frequency oscillations (HFOs) in clinical epilepsy. Prog Neurobiol (2012) 1.74

The impact of deep brain stimulation on executive function in Parkinson's disease. Brain (2000) 1.74

Electroclinical, MRI and neuropathological study of 10 patients with nodular heterotopia, with surgical outcomes. Brain (2004) 1.73

Congenital malformations due to antiepileptic drugs. Epilepsy Res (1999) 1.71

Extraneural metastases of astrocytomas and glioblastomas: clinicopathological study of two cases and review of literature. Cancer (1980) 1.71

Solitary fibrous tumour of the liver with CD34 expression. Histopathology (1996) 1.69

Selective increase in T-type calcium conductance of reticular thalamic neurons in a rat model of absence epilepsy. J Neurosci (1995) 1.64

Layer-specific genes reveal a rudimentary laminar pattern in human nodular heterotopia. Neurology (2009) 1.64

Pattern of epithelial cell proliferation in colorectal mucosa of normal subjects and of patients with adenomatous polyps or cancer of the large bowel. Cancer Res (1988) 1.62

Percutaneous intradiscal radio-frequency thermocoagulation. A cadaveric study. Spine (Phila Pa 1976) (1995) 1.62

Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol (1999) 1.57

Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain (1998) 1.56

Antiepileptic drugs as a cause of worsening seizures. Epilepsia (1998) 1.52

Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J Neurosci (1988) 1.52

Systemic granulomatous reaction to a foreign body after hip replacement. N Engl J Med (1996) 1.50

Role of acid and bile reflux in development of specialised intestinal metaplasia in distal oesophagus. Dig Liver Dis (2002) 1.49

Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease. Ann Neurol (1997) 1.48

The core assessment program for intracerebral transplantation. Mov Disord (1995) 1.47

Portal hypertensive gastropathy: reproducibility of a classification, prevalence of elementary lesions, sensitivity and specificity in the diagnosis of cirrhosis of the liver. A NIEC multicentre study. New Italian Endoscopic Club. Ital J Gastroenterol Hepatol (1997) 1.45

Responses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats: electrophysiological data. Neurosci Lett (1995) 1.43

Inhibition of levodopa effects by internal pallidal stimulation. Mov Disord (1998) 1.42

Effect of high-frequency stimulation of the subthalamic nucleus on the neuronal activities of the substantia nigra pars reticulata and ventrolateral nucleus of the thalamus in the rat. Neuroscience (2000) 1.41

[Effects of the stimulation of the subthalamic nucleus in Parkinson disease]. Rev Neurol (Paris) (1993) 1.39

Clinical characteristics and topography of lesions in movement disorders due to thalamic lesions. Neurology (2001) 1.39

Cesare Lombroso, cortical dysplasia, and epilepsy: keen findings and odd theories. Neurology (2003) 1.38

Functional mapping of cortical areas. Neurol Sci (2001) 1.38

Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs. J Cereb Blood Flow Metab (2001) 1.38

Subcellular localization and axonal transport of the survival motor neuron (SMN) protein in the developing rat spinal cord. Hum Mol Genet (2000) 1.35

Intracranial EEG and human brain mapping. J Physiol Paris (2004) 1.34

Basal ganglia involvement in rotational seizures. Epileptic Disord (1999) 1.33

Surgical treatment of drug-resistant nocturnal frontal lobe epilepsy. Brain (2006) 1.31

Diagnostic imaging in 13 cases of Rasmussen's encephalitis: can early MRI suggest the diagnosis? Neuroradiology (2003) 1.31

Bilateral subthalamic nucleus stimulation for severe Parkinson's disease. Mov Disord (1995) 1.28

Mirthful laughter induced by subthalamic nucleus stimulation. Mov Disord (2001) 1.27

The ontogeny of brain receptors for corticotropin-releasing factor and the development of their functional association with adenylate cyclase. J Neurosci (1988) 1.27

Stereotactic radiosurgery with the linear accelerator: treatment of arteriovenous malformations. Neurosurgery (1989) 1.25

Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease. Eur Respir J (1992) 1.24

Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology (2000) 1.24

Opposite motor effects of pallidal stimulation in Parkinson's disease. Ann Neurol (1998) 1.23

Central neurocytomas. Critical evaluation of a small-cell neuronal tumor. Am J Surg Pathol (1992) 1.22

Band heterotopia: correlation of outcome with magnetic resonance imaging parameters. Ann Neurol (1994) 1.22

Deep brain stimulation in the treatment of severe dystonia. J Neurol (2001) 1.19

Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nat Genet (1997) 1.18

Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation. Mov Disord (1998) 1.17

Extra-nuclear estrogen receptor GPR30 regulates serotonin function in rat hypothalamus. Neuroscience (2008) 1.17

A new approach for analyzing proton magnetic resonance spectroscopic images of brain tumors: nosologic images. Nat Med (2000) 1.17

(R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo. J Pharmacol Exp Ther (1999) 1.17

Influence of surgery and antiepileptic drugs on seizures symptomatic of cerebral tumours. Acta Neurochir (Wien) (1990) 1.17

Subcutaneous apomorphine in Parkinson's disease. J Neurol Neurosurg Psychiatry (1989) 1.16

Commission on Outcome Measurement in Epilepsy, 1994-1997: final report. Epilepsia (1998) 1.15

Study of the excitability cycle of the blink reflex in Huntington's chorea. Eur Neurol (1976) 1.13

Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta. J Neurosci (1998) 1.13

Ictal clinical and scalp-EEG findings differentiating temporal lobe epilepsies from temporal 'plus' epilepsies. Brain (2007) 1.12

EGF receptor amplification and expression in human brain tumours. Eur J Cancer (1992) 1.12

Malformations in offspring of women with epilepsy: a prospective study. Epilepsia (1999) 1.12

Prevalence of intestinal metaplasia in the distal oesophagus, oesophagogastric junction and gastric cardia in symptomatic patients in north-east Italy: a prospective, descriptive survey. The Italian Ulcer Study Group "GISU". Dig Liver Dis (2001) 1.11

Helicobacter pylori in promotion of gastric carcinogenesis. Dig Dis Sci (1996) 1.11

Stimulation of the ventral intermediate thalamic nucleus in tremor dominated Parkinson's disease and essential tremor. Acta Neurochir (Wien) (1995) 1.11

Endogenous activation of metabotropic glutamate receptors supports the proliferation and survival of neural progenitor cells. Cell Death Differ (2005) 1.10

Papillary meningioma. Clinicopathologic study of seven cases and review of the literature. Cancer (1986) 1.10

Familial schizencephaly associated with EMX2 mutation. Neurology (1997) 1.09

Compounds from Sichuan and Melegueta peppers activate, covalently and non-covalently, TRPA1 and TRPV1 channels. Br J Pharmacol (2009) 1.09

Diffuse lesions in the CNS revealed by MR imaging in a case of Whipple disease. AJNR Am J Neuroradiol (2001) 1.09

Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients. Mov Disord (1996) 1.08

Alterations of GABA-mediated synaptic transmission in human epilepsy. Adv Neurol (1986) 1.08

Effect of bilateral stimulation of the subthalamic nucleus on parkinsonian voice. Brain Lang (2001) 1.08

PHCCC, a specific enhancer of type 4 metabotropic glutamate receptors, reduces proliferation and promotes differentiation of cerebellar granule cell neuroprecursors. J Neurosci (2004) 1.07

Spitting automatism. Epileptic Disord (2000) 1.07

Anemone toxin (ATX II)-induced increase in persistent sodium current: effects on the firing properties of rat neocortical pyramidal neurones. J Physiol (1998) 1.07

Effect of stimulation of the subthalamic nucleus on oral control of patients with parkinsonism. J Neurol Neurosurg Psychiatry (1999) 1.07

Role of the hypothalamic hamartoma in the genesis of gelastic fits (a video-stereo-EEG study). Electroencephalogr Clin Neurophysiol (1995) 1.06

Silence is golden: transient neural deactivation in the prefrontal cortex during attentive reading. Cereb Cortex (2007) 1.06

Identification of subtypes of [3H]prazosin-labelled alpha 1 receptor binding sites in rat brain. Eur J Pharmacol (1985) 1.06

Contribution of dynamic contrast MR imaging to the differentiation between dural metastasis and meningioma. Neuroradiology (2004) 1.06